newsence
來源篩選

HHS Is Developing an AI Tool to Generate Hypotheses on Vaccine Injury Claims

Wired - AI

The US Department of Health and Human Services is creating a generative AI tool to analyze vaccine safety data and generate hypotheses about potential vaccine injuries. While still in development, experts express concern that its findings could be exploited by officials with anti-vaccine sentiments.

newsence

美國衛生及公共服務部正開發AI工具以生成疫苗傷害聲明的假設

Wired - AI
24 天前

AI 生成摘要

美國衛生及公共服務部(HHS)正開發一款生成式AI工具,旨在分析疫苗安全數據並生成潛在疫苗傷害的假設。儘管該工具仍在開發中,但專家擔憂其研究結果可能被帶有反疫苗立場的官員利用。

HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims | WIREDMenuMenuAccountAccountChevronExpandSearchSave StorySave StoryXLargeChevronFacebookXPinterestYouTubeInstagramTiktok

HHS Is Making an AI Tool to Create Hypotheses About Vaccine Injury Claims

Image

The US Department of Health and Human Services is developing a generative artificial intelligence tool to find patterns across data reported to a national vaccine monitoring database and to generate hypotheses on the negative effects of vaccines, according to an inventory released last week of all use cases the agency had for AI in 2025.

The tool has not yet been deployed, according to the HHS document, and an AI inventory report from the previous year shows that it has been in development since late 2023. But experts worry that the predictions it generates could be used by Health and Human Services secretary Robert F. Kennedy Jr. to further his anti-vaccine agenda.

A long-standing vaccine critic, Kenedy has upended the childhood vaccination schedule in his year in office, removing several shots from a list of recommended immunizations for all children, including those for Covid-19, influenza, hepatitis A and B, meningococcal disease, rotavirus, and respiratory syncytial virus, or RSV.

Kennedy has also called for overhauling the current safety monitoring system for vaccine injury data collection, known as Vaccine Adverse Event Reporting System, or VAERS, claiming that it suppresses information about the true rate of vaccine side effects. He has also proposed changes to the federal Vaccine Injury Compensation Program that could make it easier for people to sue for adverse events that haven’t been proven to be associated with vaccines.

Jointly managed by the Centers for Disease Control and Prevention and the Food and Drug Administration, VAERS was established in 1990 as a way to detect potential safety issues with vaccines after their approval. Anyone, including health care providers and members of the public, can submit an adverse reaction report to the database. Because these claims are not verified, VAERS data alone can’t be used to determine if a vaccine caused an adverse event.

“VAERS, at best, was always a hypothesis-generating mechanism,” says Paul Offit, a pediatrician and director of the Vaccine Education Center at Children's Hospital of Philadelphia who was previously a member of the CDC’s Advisory Council on Immunization Practices. “It's a noisy system. Anybody can report, and there’s no control group.”

Offit says the system only shows adverse events that happened at some point following immunization; it doesn’t prove that a vaccine caused those reactions. CDC’s own website says that a report to VAERS does not mean that a vaccine caused an adverse event. Despite this, anti-vaccine activists have misused VAERS data over the years to argue that vaccines are not safe.

Leslie Lenert, previously the founding director of the CDC’s National Center for Public Health Informatics, says government scientists have been using traditional natural language processing AI models to look for patterns in VAERS data for several years, so it’s not surprising that HHS would move toward the adoption of more advanced large language models.

One major limitation of VAERS is that it doesn’t include data on how many people received a vaccine, which can make events logged in the database seem more common than they actually are. For that reason, Lenert says it’s important to pair information from VAERS with other data sources to determine the true risk of an event.

LLMs are also famously good at producing convincing hallucinations, underscoring the need for humans to follow up on any hypotheses generated by an LLM.

“VAERS is supposed to be very exploratory. Some people in the FDA are now treating it as more than exploratory,” says Lenert, who is currently the director of the Center for Biomedical Informatics and Health Artificial Intelligence at Rutgers University.

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research, reportedly proposed stricter vaccine regulation in a recent memo sent to staff in which he blamed the deaths of at least 10 children on the Covid-19 vaccine without citing evidence. The deaths were reported to VAERS and had previously been reviewed by FDA staff. More than a dozen former FDA commissioners responded with a letter in The New England Journal of Medicine, expressing concern about Prasad’s proposed guidelines. The changes, they wrote, would “dramatically change vaccine regulation on the basis of a reinterpretation of selective evidence.”

Jesse Goodman, an infectious disease physician and professor of medicine at Georgetown University, says that the use of LLMs could potentially detect previously unknown safety issues with vaccines. But since VAERS can contain inaccurate and incomplete data, he says it’s important that any leads are thoroughly investigated first.

“I would expect, depending on the approaches used, a lot of false alerts and a need for a lot of skilled human follow-through by people who understand vaccines and possible adverse events, as well as statistics, epidemiology, and challenges with LLM output,” he says.

With deep staffing cuts at the CDC, Goodman says it would be important to have plans and capacity in place to deal with any emerging data, including screening it and deciding what may need to be studied further and how.

In the past, VAERS has flagged legitimate safety issues, including instances of a rare clotting disorder among some people who received the Johnson & Johnson Covid-19 vaccine and rare cases of myocarditis, particularly among younger males, who got the mRNA Covid-19 vaccines.

HHS did not respond to a request for comment.

You Might Also Like

In your inbox: WIRED's most ambitious, future-defining stories

Does the “war on protein” exist?

Big Story: China’s renewable energy revolution might save the world

The race to build the DeepSeek of Europe is on

Watch our livestream replay: Welcome to the Chinese century

Image Image Image Image Image Image Image Image Image Image Image Image Image Image

© 2026 Condé Nast. All rights reserved. WIRED may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. Ad Choices